In conclusion, we have developed a new breast cancer subtyping method called PCA-PAM50, which couples the conventional PAM50 method with PCA for selection of a gene expression–based ER-balanced subset as the first step for intrinsic subtyping. The gene discussed is ESR1; the disease is breast carcinoma.